Early Detection Research Network


This biomarker is also known as:
  • histone H2B.1 A,
  • Histone H2B.a,
  • H2B histone family, member G,
  • H2B/a,
  • H2BFA,
  • H2B/g,
  • histone H2B type 1-C/E/F/G/I,
  • histone cluster 1, H2bf,
  • H2B/k,
  • Histone H2B.k,
  • Histone H2B.l,
  • H2BFK,
  • histone H2B.g,
  • Histone H2B.1 A,
  • H2BFL,
  • Histone H2B.h,
  • H2B/h,
  • H2BFG,
  • HIST1H2BF,
  • H2B/l,
  • H2BFH,
  • Histone H2B.g,
  • histone 1, H2bf,


histone cluster 1, H2bf


There are no datasets associated with this biomarker.

QA State: Curated
Type: Gene

The following organs have data associated with this biomarker…


Phase: One
QA State: Curated


Performance Comment

Significance Analysis of Microarray (SAM) was used to develop a 7-gene classifier. The overall prediction accuracy and sensitivity is 71% and 76%, respectively. The inclusion of the Gleason sum to the seven-gene classifier raised the prediction accuracy and sensitivity to 83% and 76% respectively This prognostic signature is closely associated with biochemical recurrence in patients after radical prostatectomy. The seven genes are: RRAGD, PQBP1, HIST1H2BC (HIST1H2BE, HIST1H2BF, HIST1H2BI), ALDH1A2, TRIM22, RBPMS, HSPB8.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.